Twist Bioscience Corp reports results for the quarter ended in June - Earnings Summary

Twist Bioscience

02/08/2024 14:32

* Twist Bioscience Corp  TWST.OQ  reported a quarterly
adjusted
loss of $1.47​​ per share for the quarter ended in June, lower
than the same quarter last year, when the company reported EPS
of -78 cents.  The mean expectation of eleven analysts for the
quarter was for a loss of 77 cents per share. Wall Street
expected results to range from -81 cents to -73 cents per share.
    * Revenue rose 27.8% to $81.46 million from a year ago;
analysts
expected $77.40 million. 
    * Twist Bioscience Corp's reported EPS for the quarter was a
loss
of $1.47​.
    * The company reported a quarterly loss of $85.57 million.
    * Twist Bioscience Corp shares had risen by 7.7% this
quarter and
gained 43.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Twist Bioscience
Corp is $54.00 
This summary was machine generated from LSEG data August 2 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.77          -1.47          Missed
 Mar. 31 2024      -0.82          -0.79          Beat
 Dec. 31 2023      -0.78          -0.75          Beat
 Sep. 30 2023      -0.92          -0.81          Beat